侵袭性真菌感染的经验性和抢先治疗(3)
| 第1页 |
参见附件。
[6] Ostrosky-Zeichner L， Alexander BD， Kett DH， et al. Multicenter clinical evaluation of the (1-3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans [J]. Clin Infect Dis， 2005， 41(5)： 654-659.
[7] Greene RE， Schlamm HT， Oestmann JW， et al. Imaging findings in acute invasive pulmonary aspergillosis： clinical significance of the halo sign [J]. Clin Infect Dis， 2007， 44(3)： 373-379.
[8] Mengoli C， Cruciani M， Barnes RA， et al. Use of real-time PCR for diagnosis of invasive aspergillosis： systemic review and meta-analysis [J]. Lancet Infect Dis， 2009， 9(5)： 89-96.
[9] Barnes RA， White PL， Bygrave C， et al. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients [J]. J Clin Pathol， 2009， 62(1)： 64-69.
[10] Maertens J， Theunissen K， Verhoef G， et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection： a prospective feasibility study [J]. Clin Infect Dis， 2005， 41(9)： 1242-1250.
[11] Cordonnier C， Pautas C， Maury S， et al. Empirical versus preemptive antifungal therapy for high-risk， febrile， neutropenic patients： a randomized， controlled trial [J]. Clin Infect Dis， 2009， 48(8)： 1042-1051.
(收稿日期：2013-09-05)
您现在查看是摘要介绍页，详见PDF附件。